Abstract:OBJECTIVE:To describe the essential points for the correct diagnosis and best treatment for ovarian growing teratoma syndrome (GTS) developed after surgery and chemotherapy for ovarian immature teratoma.METHODS:Retrospective review of the clinical characteristics and long term follow up results of 22 cases of ovarian GTS to illustrate the unique biological behavior of the tumor and good prognosis of the disease.RESULTS:Pathological examination of the tumors revealed completely benign mature teratoma with G0 grading in 20 cases. The other 2 cases were found to be G0 mature teratoma with concurrent association of malignant somatic cell tumor: carcinoid and primitive neuroectodermal tumor (PNET) respectively. Among the 22 cases of ovarian GTS there are 6 cases with recurrent tumors developed repeatedly, so totally surgical treatments had been performed for 31 times. Time interval in between the development of the ovarian GTS and the initial surgery for their primary immature teratoma is equal to or exceeding one year in 94% (29/31) of the cases. Such a time factor is of high significance for the diagnosis of ovarian GTS. As the benign behavior of the ovarian GTS together with its poor response to chemotherapy have just been recognized in recent years, they were treated as malignant tumors as their original primary immature teratoma before the year of 1987. Postoperative chemotherapy of various kinds was applied. By the year of 1988 postoperative chemotherapy began to be abandoned and since then most of the patients (9/10) had not received postoperative chemotherapy. After long periods of follow up (3.6 -23.0 years) 20 of the 22 patients are found to be living and well. The rest 2 patients died of the concurrent association of malignant somatic cell tumors with carcinoid and PNET in 0.1 and 0.3 years respectively.CONCLUSIONS:Ovarian GTS is a tumor developed after surgical and chemotherapeutic treatment of malignant ovarian immature teratoma. Pathologic grading of the tumors showed retroconversion of the malignancy of the tumor from G3, G2 or G1 to G0 with good prognosis. The tumor usually remained to be quiescent for long periods of time. But there are also some potential of progressive growth, the tumor may grow to huge size and the recurrent tumor may develop repeatedly for several times more than 10 or 20 years later. Surgical removal should be the main treatment either for the primary or the recurrent tumors. Chemotherapy and radiotherapy are not effective and can do nothing but harm to patients. Only correct knowledge about the benign biological behavior of the ovarian GTS and reasonable therapeutic regimen can have the disease ends with good prognosis.

Neuroendocrine differentiation in a metachronous metastatic deposit in a case of mature growing ovarian teratoma: A rare occurrence

Clinicopathologic Characteristics and Survival Outcomes in Neuroendocrine Carcinoma of the Ovary

Pelvic mature cystic teratoma with neuroendocrine carcinoma: report of a rare association and review of literature

Neuroendocrine carcinoma arising within a retroperitoneal mature teratoma

Clinical Considerations and Prognosis of Well-Differentiated Neuroendocrine Tumor Occurring Within a Renal Teratoma—A Case Series

Growing Teratoma Syndrome Following Primary Ovarian Immature Teratoma: Two Cases And Review Of Literature

Mature Teratoma in a Supernumerary Ovary in a Child: Report of the First Case

Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease

Teratoid carcinosarcoma of the ovary with prominent neuroectodermal differentiation

Types and Frequency of Neural Elements in Mature Ovarian Teratomas: An 11-Year Study from Rural India

Growing teratoma syndrome of the ovary: a case report and literature review

Growing teratoma syndrome: diagnostic challenges and outcomes

Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation

Growing teratoma syndrome of the ovary: a case report with FDG-PET findings

Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report

Metastasis from follicular lymphoma to an ovarian mature teratoma: a case report of tumor-to-tumor metastasis

Clinicopathologic feature and treatment progress of high-grade ovarian neuroendocrine tumors

Synchronous Bilateral Ovarian Teratoma with Malignant Transformation: A Rare Occurrence

Immature Teratoma With Metastatic Gliosis

[Ovarian Growing Teratoma Syndrome Clinical Study of 22 Cases].

Neuroendocrine carcinoma arising in a mediastinal teratoma with pulmonary metastasis: a case report and the chemotherapy response